Development of a Novel Circulating Autoantibody Biomarker Panel for the Identification of Patients with ‘Actionable’ Pulmonary Nodules

SIMPLE SUMMARY: Circulating biomarkers for the identification of patients with “actionable” nodules may increase screening uptake and decrease false-positive rates associated with low-dose computed tomography (LDCT). Novel autoantibody biomarkers were identified utilizing a HuProt™ protein microarra...

Descripción completa

Detalles Bibliográficos
Autores principales: Auger, Claire, Moudgalya, Hita, Neely, Matthew R., Stephan, Jeremy T., Tarhoni, Imad, Gerard, David, Basu, Sanjib, Fhied, Cristina L., Abdelkader, Ahmed, Vargas, Moises, Hu, Shaohui, Hulett, Tyler, Liptay, Michael J., Shah, Palmi, Seder, Christopher W., Borgia, Jeffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136536/
https://www.ncbi.nlm.nih.gov/pubmed/37190187
http://dx.doi.org/10.3390/cancers15082259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136536/
https://www.ncbi.nlm.nih.gov/pubmed/37190187
http://dx.doi.org/10.3390/cancers15082259

Ejemplares similares